SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001140361-24-046170 from Kronos Bio, Inc. (KRON) (CIK 0001741830)

Kronos Bio, Inc. (KRON) (CIK 0001741830)
Date: Nov. 12, 2024 · CIK: 0001741830 · Accession: 0001140361-24-046170

AI Filing Summary & Sentiment

File numbers found in text: 333-283072

Date
November 12, 2024
Author
Not clearly detected
Form
CORRESP
Company
Kronos Bio, Inc. (KRON) (CIK 0001741830)

Letter

KRONOS BIO, INC.

1300 So. El Camino Real, Suite 400

San Mateo, California 94402

November 12, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn:

Tim Buchmiller

Re:

Kronos Bio, Inc.

Registration Statement on Form S-3 (File No. 333-283072)

Request for Acceleration of Effective Date

Ladies and Gentlemen:

Kronos Bio, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on November 14, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Charles J. Bair of Cooley LLP and Asa M. Henin of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Asa M. Henin at (858) 550-6104, or in his absence, Charles J. Bair at (858) 550-6142.

Very truly yours,
Kronos Bio, Inc.

Show Raw Text
CORRESP
1
filename1.htm

  KRONOS BIO, INC.

    1300 So. El Camino Real, Suite 400

  San Mateo, California 94402

    November 12, 2024

    VIA EDGAR

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    100 F Street, N.E.

    Washington, D.C. 20549

            Attn:

              Tim Buchmiller

                Re:

                  Kronos Bio, Inc.

                    Registration Statement on Form S-3 (File No. 333-283072)

                      Request for Acceleration of Effective Date

          Ladies and Gentlemen:

          Kronos Bio, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on November 14, 2024, at
            4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Charles J. Bair of Cooley LLP and Asa M. Henin of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

           Once the Registration Statement has been declared effective, please orally confirm that event with Asa M. Henin at (858)
            550-6104, or in his absence, Charles J. Bair at (858) 550-6142.

          Very truly yours,

          Kronos Bio, Inc.

          /s/ Norbert Bischofberger, Ph.D.

          By:

          Norbert Bischofberger, Ph.D.

          Title:

          President and Chief Executive Officer